Tech Company Financing Transactions

TenNor Therapeutics Funding Round

TenNor Therapeutics secured a $25 million Series B funding round on 9/20/2016. Investors included Northern Light Venture Capital, Frontline Ventures and Oriza Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

218 Xinghu St. Building B2 Room 711
Suzhou Industrial Park, 215123
China

Phone

+0512-86861990

Website

www.tennorx.com

Email Address

[email protected]

Overview

TenNor Therapeutics was established in 2013 with operations in the historic city of Suzhou, China. The company specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Zhenkun Ma

        

Browse more venture capital transactions:

Prev: 9/20/2016: Human Security venture capital transaction
Next: 9/20/2016: IRYStec venture capital transaction

Share this article

About Our VC Transactions Data

We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary